Your browser doesn't support javascript.
loading
Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults.
Priddy, Frances H; Williams, Michael; Carson, Simon; Lavender, Brittany; Mathieson, Julia; Frampton, Chris; Moreland, Nicole J; McGregor, Reuben; Williams, Georgia; Brewerton, Maia; Gell, Katie; Ussher, James; Le Gros, Graham.
Affiliation
  • Priddy FH; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand. Electronic address: fpriddy@malaghan.org.nz.
  • Williams M; Pacific Clinical Research Network, 1289 Haupapa St, Rotorua 3010, New Zealand.
  • Carson S; Pacific Clinical Research Network, 1289 Haupapa St, Rotorua 3010, New Zealand.
  • Lavender B; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand.
  • Mathieson J; Pacific Clinical Research Network, 1289 Haupapa St, Rotorua 3010, New Zealand.
  • Frampton C; University of Otago, 2 Riccarton Ave, Christchurch 8011, New Zealand.
  • Moreland NJ; University of Auckland, 2 Park Rd, Grafton Auckland 1023, New Zealand.
  • McGregor R; University of Auckland, 2 Park Rd, Grafton Auckland 1023, New Zealand.
  • Williams G; Pacific Clinical Research Network, 1289 Haupapa St, Rotorua 3010, New Zealand.
  • Brewerton M; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand; Department of Clinical Immunology & Allergy, Auckland City Hospital, 2 Park Rd, Grafton Auckland 1023, New Zealand.
  • Gell K; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand.
  • Ussher J; Vaccine Alliance Aotearoa New Zealand and University of Otago, 362 Leith St, Dunedin 9016 New Zealand.
  • Le Gros G; Vaccine Alliance Aotearoa New Zealand and Malaghan Institute of Medical Research, PO Box 7060, Wellington 6242, New Zealand.
Vaccine ; 40(34): 5050-5059, 2022 08 12.
Article in En | MEDLINE | ID: mdl-35868948

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: Vaccine Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: En Journal: Vaccine Year: 2022 Document type: Article